Neonatal AAV gene therapy rescues hearing in a mouse model of SYNE4 deafness-Reference-Cited by-同舟云学术

Neonatal AAV gene therapy rescues hearing in a mouse model of SYNE4 deafness

Published:2020-12-22 Issue:2 Volume:13 Page:
ISSN:1757-4676
Container-title:EMBO Molecular Medicine
language:en
Short-container-title:EMBO Mol Med

Author:

Taiber Shahar¹^ORCID,Cohen Roie²,Yizhar‐Barnea Ofer¹^ORCID,Sprinzak David²^ORCID,Holt Jeffrey R³^ORCID,Avraham Karen B¹^ORCID

Affiliation:

1. Department of Human Molecular Genetics & Biochemistry Sackler Faculty of Medicine & Sagol School of Neuroscience Tel Aviv University Tel Aviv Israel

2. School of Neurobiology, Biochemistry and Biophysics George S. Wise Faculty of Life Sciences Tel Aviv University Tel Aviv Israel

3. Departments of Otolaryngology & Neurology Boston Children’s Hospital & Harvard Medical School Boston MA USA

Funder

National Institute on Deafness and Other Communication Disorders

Capita Foundation

H2020 European Research Council

Publisher

EMBO

Subject

Molecular Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.15252/emmm.202013259

Reference41 articles.

1. Dual AAV-mediated gene therapy restores hearing in a DFNB9 mouse model

2. Targeted genomic capture and massively parallel sequencing to identify genes for hereditary hearing loss in middle eastern families

3. Spectrum of genes for inherited hearing loss in the Israeli Jewish population, including the novel human deafness gene ATOH1

4. Nesprins in health and disease

5. Encoding of conditioned fear in central amygdala inhibitory circuits

Cited by 40 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. YEATS domain-containing protein GAS41 regulates nuclear shape by working in concert with BRD2 and the mediator complex in colorectal cancer;Pharmacological Research;2024-08

2. Gene therapy advancements for the treatment of acquired and hereditary hearing loss;Frontiers in Audiology and Otology;2024-07-17

3. Nesprin proteins: bridging nuclear envelope dynamics to muscular dysfunction;Cell Communication and Signaling;2024-04-02

4. Clinical practice guidelines for gene therapy to treat hereditary hearing loss;Interdisciplinary Medicine;2024-03-16

5. Clarin-2 gene supplementation durably preserves hearing in a model of progressive hearing loss;Molecular Therapy;2024-03